Quality Payments

Quality Payments

Please note, the declaration period for claiming for a Quality Payment for the February 2019 review point (15th February 2019) has now closed. Contractors who did not make their declaration by 11.59pm on Friday 1st March 2019 have missed the deadline and will therefore not be paid a Quality Payment.

A decision has not yet been made on the future of the Quality Payments Scheme; this will be discussed in the forthcoming negotiations with NHS England and the Department of Health and Social Care.

A Quality Payments Scheme, which forms part of the Community Pharmacy Contractual Framework, was introduced from 1st December 2016. The original version of the scheme ran until 31st March 2018 and a total of £75 million was paid to community pharmacies for meeting the specified quality criteria.

The scheme was extended in March 2018 for the first six months of 2018/19, as part of interim arrangements prior to substantive negotiations for 2018/19 being undertaken. The extended Scheme had a review point in June 2018 and funding of £37.5 million.

In September 2018, a new Quality Payments Scheme was announced for the remainder of the 2018/19 financial year. The new scheme has funding of £37.5 million and a review point in February 2019. Changes to the Scheme are summarised in PSNC Briefing 051/18: A summary of the second Quality Payments Scheme 2018/19.

Click on a heading below for more information.

Guidance documents

NHS England guidance

NHS England has published guidance for the February 2019 review point of the Quality Payments Scheme. The new guidance should be read in conjunction with NHS England’s previously published gateway criteria and quality criteria guidance:

  • NHS England – Pharmacy Quality Payments Gateway Criteria Guidance (published 23rd December 2016); and
  • NHS England – Pharmacy Quality Payments Quality Criteria Guidance (published 27th February 2017).

These documents are available on the NHS England website.

PSNC guidance

PSNC Briefing 051/18: A summary of the second Quality Payments Scheme 2018/19

PSNC Briefing 065/18: Quality Payments – Evidence checklist

PSNC Briefing 066/18: Quality Payments – PSNC resources

PSNC Briefing 007/19: Quality Payments – Completing your declaration

Gateway criteria

To be eligible to collect the points necessary to claim a Quality Payment, the contractor must meet five gateway criteria:

Click on the link below for more information on each gateway criterion:

Contractors passing the gateway criteria will only receive a Quality Payment if they meet one or more of the quality criteria listed in the table under the ‘Quality criteria’ subheading below. Therefore, meeting the gateway criteria will not, in itself, attract a Quality Payment; it is subject to how many of the quality criteria the contractor meets.

Quality criteria

Contractors passing the gateway criteria will receive a Quality Payment if they meet one or more of the quality criteria listed in the table below. Each criterion is designated a number of points and the total number of points that each contractor can qualify for is 100.

Click on the link below for more information on each quality criterion:

Domain Criteria Points
Patient Safety

A written patient safety report (updated since 29 June 2018, i.e. the last review date or covering the last year if not previously claimed) at premises level available for inspection at review point covering analysis of incidents and incident patterns (taken from an ongoing log), evidence of sharing learning locally and nationally, and actions taken in response to national patient safety alerts;

and Demonstrably, the pharmacy contractor actively identifies and manages the risks at premises level associated with specified look-alike sound-alike errors (LASA) identified from the National Reporting and Learning System NRLS)**. Demonstrably, the pharmacy contractor has put in place actions to prevent these, for example physical separation, staff awareness raising, visual warnings, tags or labels on shelving, fatigue reduction strategies, enhanced checking procedures for these medicines. 

Demonstrably, the pharmacy contractor uploads any LASA incident reports to the NRLS and keeps a record for confirmation of this activity at the pharmacy premises or within any electronic reporting system used by the contractor. In the description of what happened in the NRLS report, the contractor must include the text ‘LASA’ as a unique identifier to facilitate future national learning.

** NHS Improvement top combinations by likelihood and harm caused – propranolol and prednisolone, amlodipine and amitriptyline, carbamazepine and carbimazole, azathioprine and azithromycin, atenolol and allopurinol.

Patient Safety

On the day of the review, 80% of all registered pharmacy professionals working at the pharmacy have satisfactorily completed the CPPE Risk Management training;

and the pharmacy has available for inspection at the review point, at premises level, an example of a risk review that the pharmacy team at the premises have drawn up for a risk in that pharmacy that has been identified and prioritised with identified risk minimisation actions that the pharmacy team is taking.

Patient Safety On the day of the review the pharmacy must have completed the audit of non-steroidal anti-inflammatory drugs and gastro-protection for patients 65 or over, notified the patient’s GP where professional concerns were identified, share their anonymised data with NHS England and incorporated the learning of the audit into future practice. 20
Public Health

On the day of the review the pharmacy is a Healthy Living Pharmacy level 1 (self-assessment) and;

80% of staff working at the pharmacy (including pharmacy professionals) that provide healthcare advice to the public have successfully completed the CPPE children’s oral health training assessment.

Digital/Urgent Care On the day of the review, the pharmacy’s NHS 111 Directory of Services entry is up to date. 2.5
Clinical Effectiveness

On the day of the review, the pharmacy can show evidence of asthma patients, for whom more than 6 short acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a 6 month period, have since 29th June 2018 (i.e. the last review date) been referred to an appropriate health care professional for an asthma review; and 

Can evidence that they have ensured that all children aged 5-15 years prescribed an inhaled corticosteroid for asthma have a spacer device where appropriate and have a personalised asthma action plan. Refer to an appropriate healthcare professional where this is not the case.

Workforce On the day of the review, 80% of all pharmacy staff working in patient facing roles are Dementia Friends (Alzheimer’s Society). 2.5
Total number of points: 100

Claiming Quality Payments and validation of the gateway criteria

Community pharmacy contractors will be able to make a declaration for a Quality Payment for the 15th February 2019 review point between Monday 4th February 2019 at 9am and Friday 1st March 2019 at 11.59pm.

As for previous declarations, contractors wishing to claim a Quality Payment will be required to submit their declaration online to the NHS Business Services Authority (NHSBSA); however, for the February 2019 review point, contractors will be able to claim for a Quality Payment via one of two routes, the Snap Survey tool (as used for previous declarations) or the Manage Your Service (MYS) application. In addition, there will be a new process for validating a contractor’s submission to confirm if they meet the gateway criteria and actions that contractors will need to take if NHSBSA cannot validate that a contractor’s submission meets all five of the gateway criteria.

PSNC has published 007/19: Quality Payments – Completing your declaration which provides further information on how to make a declaration and the validation process for the gateway criteria.

Payment information

Contractors that successfully meet the requirements will receive a Quality Payment which will be funded from a £37.5 million budget. The funding will be divided between qualifying pharmacies based on the number of points they have achieved, up to a maximum of £64 per point. Each point will have a minimum value worth £32 (which is the value of each point if all pharmacy contractors achieved maximum points). Payments will be made to eligible contractors depending on how many quality criteria they have met (and therefore how many ‘points’ they achieved).

Pharmoutcomes support

Community pharmacy contractors are now able to access support on PharmOutcomes for the Quality Payments Scheme’s February 2019 review point. This support is available to all contractors free of charge as PSNC has agreed to use their licence to provide access to this support.

The following support is available on PharmOutcomes to assist contractors:

  • Quality Payments Scheme assessment framework: contractors and their teams can track their progress with achieving the Quality Payments criteria;
  • Patient safety report quality criterion: Contractors can complete their annual patient safety report on PharmOutcomes and a report of this can then be printed out, if required, as evidence of meeting the patient safety report element of the quality criterion;
  • Non-steroidal anti-inflammatory drugs (NSAID) audit quality criterion: contractors can use PharmOutcomes to directly enter their audit data and submit this to the NHSBSA; a permanent patient record will be stored on PharmOutcomes and contractors can send automatic referrals to the patients’ GP practices (if required); and
  • Asthma referrals quality criterion: contractors can use PharmOutcomes to send electronic referrals to GP practices in relation to the asthma criterion for patients that may benefit from an asthma review.

The Quality Payments Scheme assessment framework can be accessed by logging in and selecting ‘Assessments’. The other support listed above can be found under the ‘Services’ section; the NSAID audit is listed under the ‘National audits’ section and the other support is listed under ‘Quality Payment Criteria’.

If a contractor has not used PharmOutcomes before, log in details can be obtained by sending a message to the PharmOutcomes helpdesk. Contractors will need to provide details of the pharmacy, contact information and an email address to issue the login details to. 

CPPE support

The Centre for Pharmacy Postgraduate Education (CPPE) has created a Quality Payments page on their website. The page provides links to the CPPE training which is required to be completed to meet the Healthy Living Pharmacy and risk managament quality criteria.

Declaration data for previous review points

The NHSBSA has published the declaration data for the April 2017, November 2017 and June 2018 review points of the Quality Payments Scheme.

Further information can be found on the Quality Payments Scheme – Statistics page.

PSNC webinar and slide deck


FAQs on the Quality Payments Scheme are available on the Quality Payments – FAQs page.

Latest Services and Commissioning news

View more Services and Commissioning news >